
Eric K. Nicholson
Examiner (ID: 1800)
| Most Active Art Unit | 3501 |
| Art Unit(s) | 3508, 3642, 2899, 3744, 3501, 3627, 3629, 3626, PQT, 3679 |
| Total Applications | 2110 |
| Issued Applications | 1732 |
| Pending Applications | 114 |
| Abandoned Applications | 263 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10040319
[patent_doc_number] => 09081020
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-07-14
[patent_title] => 'Mutant proteins and methods for selecting them'
[patent_app_type] => utility
[patent_app_number] => 12/866594
[patent_app_country] => US
[patent_app_date] => 2009-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 13926
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 127
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12866594
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/866594 | Mutant proteins and methods for selecting them | Feb 4, 2009 | Issued |
Array
(
[id] => 8784128
[patent_doc_number] => 08430968
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-04-30
[patent_title] => 'Method of extracting starches and sugar from biological material using controlled cavitation'
[patent_app_type] => utility
[patent_app_number] => 12/357465
[patent_app_country] => US
[patent_app_date] => 2009-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 2010
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12357465
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/357465 | Method of extracting starches and sugar from biological material using controlled cavitation | Jan 21, 2009 | Issued |
Array
(
[id] => 6264998
[patent_doc_number] => 20100297674
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-25
[patent_title] => 'NOVEL CELL LINES EXPRESSING NaV AND METHODS USING THEM'
[patent_app_type] => utility
[patent_app_number] => 12/864124
[patent_app_country] => US
[patent_app_date] => 2009-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9645
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0297/20100297674.pdf
[firstpage_image] =>[orig_patent_app_number] => 12864124
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/864124 | NOVEL CELL LINES EXPRESSING NaV AND METHODS USING THEM | Jan 21, 2009 | Abandoned |
Array
(
[id] => 5458204
[patent_doc_number] => 20090258356
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-15
[patent_title] => 'Modulators of the transporter ABCD3 for treating acne or hyperseborrhea'
[patent_app_type] => utility
[patent_app_number] => 12/320174
[patent_app_country] => US
[patent_app_date] => 2009-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5917
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0258/20090258356.pdf
[firstpage_image] =>[orig_patent_app_number] => 12320174
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/320174 | Modulators of the transporter ABCD3 for treating acne or hyperseborrhea | Jan 20, 2009 | Abandoned |
Array
(
[id] => 4595516
[patent_doc_number] => 07981629
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-07-19
[patent_title] => 'Methods of isolating dermal papilla cells'
[patent_app_type] => utility
[patent_app_number] => 12/352985
[patent_app_country] => US
[patent_app_date] => 2009-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 23167
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/981/07981629.pdf
[firstpage_image] =>[orig_patent_app_number] => 12352985
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/352985 | Methods of isolating dermal papilla cells | Jan 12, 2009 | Issued |
Array
(
[id] => 5480645
[patent_doc_number] => 20090203602
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-13
[patent_title] => 'Compositions and methods for diagnosis and treatment of type 2 diabetes'
[patent_app_type] => utility
[patent_app_number] => 12/319883
[patent_app_country] => US
[patent_app_date] => 2009-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 47285
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20090203602.pdf
[firstpage_image] =>[orig_patent_app_number] => 12319883
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/319883 | Compositions and methods for diagnosis and treatment of type 2 diabetes | Jan 11, 2009 | Abandoned |
Array
(
[id] => 5584990
[patent_doc_number] => 20090104192
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-23
[patent_title] => 'Monoclonal Antibodies to Hepatocyte Growth Factor'
[patent_app_type] => utility
[patent_app_number] => 12/342059
[patent_app_country] => US
[patent_app_date] => 2008-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 10811
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0104/20090104192.pdf
[firstpage_image] =>[orig_patent_app_number] => 12342059
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/342059 | Monoclonal Antibodies to Hepatocyte Growth Factor | Dec 21, 2008 | Abandoned |
Array
(
[id] => 6165646
[patent_doc_number] => 20110195433
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-11
[patent_title] => 'Methods for Screening of Opioid Receptor Neutral Antagonists and Inverse Agonists and Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 12/808852
[patent_app_country] => US
[patent_app_date] => 2008-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 11223
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0195/20110195433.pdf
[firstpage_image] =>[orig_patent_app_number] => 12808852
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/808852 | Methods for Screening of Opioid Receptor Neutral Antagonists and Inverse Agonists and Uses Thereof | Dec 15, 2008 | Abandoned |
Array
(
[id] => 5585417
[patent_doc_number] => 20090104619
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-23
[patent_title] => 'Human G-Protein Coupled Receptors'
[patent_app_type] => utility
[patent_app_number] => 12/332174
[patent_app_country] => US
[patent_app_date] => 2008-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 16278
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0104/20090104619.pdf
[firstpage_image] =>[orig_patent_app_number] => 12332174
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/332174 | Human G-Protein Coupled Receptors | Dec 9, 2008 | Abandoned |
Array
(
[id] => 5393640
[patent_doc_number] => 20090210953
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-20
[patent_title] => 'Identification of TRPML3 (MCOLN3) as a salty taste receptor and use in assays for identifying taste (salty) modulators and/or therapeutics that modulate sodium transport, absorption or excretion and/or aldosterone, and/or vasopressin production or release'
[patent_app_type] => utility
[patent_app_number] => 12/328887
[patent_app_country] => US
[patent_app_date] => 2008-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 38
[patent_no_of_words] => 61518
[patent_no_of_claims] => 79
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0210/20090210953.pdf
[firstpage_image] =>[orig_patent_app_number] => 12328887
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/328887 | Identification of TRPML3 (MCOLN3) as a salty taste receptor and use in assays for identifying taste (salty) modulators and/or therapeutics that modulate sodium transport, absorption or excretion and/or aldosterone, and/or vasopressin production or release | Dec 4, 2008 | Abandoned |
Array
(
[id] => 5422429
[patent_doc_number] => 20090148884
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-11
[patent_title] => 'LAT1 TRANSPORTERS EXPRESSED IN BLOOD BRAIN BARRIER CELLS'
[patent_app_type] => utility
[patent_app_number] => 12/267503
[patent_app_country] => US
[patent_app_date] => 2008-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 18420
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20090148884.pdf
[firstpage_image] =>[orig_patent_app_number] => 12267503
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/267503 | LAT1 TRANSPORTERS EXPRESSED IN BLOOD BRAIN BARRIER CELLS | Nov 6, 2008 | Abandoned |
Array
(
[id] => 5264413
[patent_doc_number] => 20090117098
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-07
[patent_title] => 'Complement C1Q Inhibitors For The Prevention And Treatment Of Glaucoma'
[patent_app_type] => utility
[patent_app_number] => 12/262841
[patent_app_country] => US
[patent_app_date] => 2008-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3048
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0117/20090117098.pdf
[firstpage_image] =>[orig_patent_app_number] => 12262841
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/262841 | Complement C1Q Inhibitors For The Prevention And Treatment Of Glaucoma | Oct 30, 2008 | Abandoned |
Array
(
[id] => 5284445
[patent_doc_number] => 20090098120
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-16
[patent_title] => 'Compositions and methods for the treatment of immune related diseases'
[patent_app_type] => utility
[patent_app_number] => 12/290404
[patent_app_country] => US
[patent_app_date] => 2008-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 106
[patent_figures_cnt] => 106
[patent_no_of_words] => 44422
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12290404
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/290404 | Compositions and methods for the treatment of immune related diseases | Oct 28, 2008 | Abandoned |
Array
(
[id] => 5409564
[patent_doc_number] => 20090123462
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-14
[patent_title] => 'FGFR AGONISTS'
[patent_app_type] => utility
[patent_app_number] => 12/258028
[patent_app_country] => US
[patent_app_date] => 2008-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4710
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0123/20090123462.pdf
[firstpage_image] =>[orig_patent_app_number] => 12258028
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/258028 | FGFR AGONISTS | Oct 23, 2008 | Abandoned |
Array
(
[id] => 5410038
[patent_doc_number] => 20090123937
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-14
[patent_title] => 'Methods of selecting epidermal growth factor receptor (EGFR) binding agents'
[patent_app_type] => utility
[patent_app_number] => 12/288341
[patent_app_country] => US
[patent_app_date] => 2008-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 15248
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0123/20090123937.pdf
[firstpage_image] =>[orig_patent_app_number] => 12288341
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/288341 | Methods of selecting epidermal growth factor receptor (EGFR) binding agents | Oct 16, 2008 | Issued |
Array
(
[id] => 5575914
[patent_doc_number] => 20090143276
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-04
[patent_title] => 'Trimeric IL-1Ra'
[patent_app_type] => utility
[patent_app_number] => 12/247897
[patent_app_country] => US
[patent_app_date] => 2008-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 16122
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20090143276.pdf
[firstpage_image] =>[orig_patent_app_number] => 12247897
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/247897 | Trimeric IL-1Ra | Oct 7, 2008 | Abandoned |
Array
(
[id] => 6264792
[patent_doc_number] => 20100297638
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-25
[patent_title] => 'MOLECULAR ADAPTORS'
[patent_app_type] => utility
[patent_app_number] => 12/681643
[patent_app_country] => US
[patent_app_date] => 2008-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 20518
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0297/20100297638.pdf
[firstpage_image] =>[orig_patent_app_number] => 12681643
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/681643 | Molecular adaptors | Oct 5, 2008 | Issued |
Array
(
[id] => 5392152
[patent_doc_number] => 20090209465
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-20
[patent_title] => 'MCT1 Transporters Expressed in Blood Brain Barrier Cells'
[patent_app_type] => utility
[patent_app_number] => 12/246381
[patent_app_country] => US
[patent_app_date] => 2008-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 17254
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0209/20090209465.pdf
[firstpage_image] =>[orig_patent_app_number] => 12246381
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/246381 | MCT1 Transporters Expressed in Blood Brain Barrier Cells | Oct 5, 2008 | Abandoned |
Array
(
[id] => 5409581
[patent_doc_number] => 20090123479
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-14
[patent_title] => 'IMMUNOGLOBULINS'
[patent_app_type] => utility
[patent_app_number] => 12/245426
[patent_app_country] => US
[patent_app_date] => 2008-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 18502
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0123/20090123479.pdf
[firstpage_image] =>[orig_patent_app_number] => 12245426
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/245426 | IMMUNOGLOBULINS | Oct 2, 2008 | Abandoned |
Array
(
[id] => 4639289
[patent_doc_number] => 08017316
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-09-13
[patent_title] => 'Methods and compositions for the identification of insect repellent compounds'
[patent_app_type] => utility
[patent_app_number] => 12/283670
[patent_app_country] => US
[patent_app_date] => 2008-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 24
[patent_no_of_words] => 14178
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 119
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/017/08017316.pdf
[firstpage_image] =>[orig_patent_app_number] => 12283670
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/283670 | Methods and compositions for the identification of insect repellent compounds | Sep 14, 2008 | Issued |